[Customer Testimonial] EPIbeam pretreatment quality assurance saves time, releases resources and enhances flexibility at the Léon Bérard Center
- September 8, 2020
Since it began using EPIbeam pretreatment quality assurance (QA) in March 2019, the Léon Bérard Center in Lyon, France, has achieved a 65% reduction in machine time dedicated to QA, allowing more patients to receive valuable SBRT treatments every week.
[Article] Comparison of post therapy 90Y positron emission tomography/computed tomography dosimetry methods in liver therapy with 90Y microspheres
- August 22, 2020
Dr. Karin Knešaurek
World J Nucl Med 2020;19:359-65.
EANM’20 VIRTUAL CONGRESS
- August 15, 2020
Annual Congress of the European Association of Nuclear Medicine (EANM)
October 22-30, 2020
APMP Seminar 2020
- August 5, 2020
2nd Seminar APMP (The Association des Physiciens Médicaux du Privé)
October 10, 2020
Hôtel Pullman Paris La Défense, France
[Article] Comparison of Commercial Dosimetric Software Platforms in Patients treated with 177Lu-DOTATATE for Peptide Receptor Radionuclide Therapy
- July 31, 2020
Erick Mora-Ramireza, Lore Santoro, Emmanuelle Cassol, Juan C. Ocampo-Ramos and Naomi Clayton, Gunjan Kayal, et al.
Med. Phys. 47 (9), September 2020 0094-2405/2020/47(9)/4602/14
Joint AAPM-COMP Virtual Meeting
- June 12, 2020
Joint AAPM-COMP Annual Meeting (The American Association of Physicists in Medicine)
July 12-16, 2020
[Article] A head-to-head Comparison between Two Commercial Software Packages for Hybrid Dosimetry after Peptide Receptor Radionuclide Therapy
- June 1, 2020
Daphne M. V. Huizing, Steffie M. B. Peters, Michelle W. J. Versleijen, Esther Martens, Marcel Verheij et al.
EJNMMI Physics (2020) 7:36 https://doi.org/10.1186/s40658-020-00308-9
Season’s Greetings 2020 from DOSIsoft
- December 19, 2019
Merry Christmas & Happy New Year 2020! We thank you for all the support & trust you bring to improve cancer treatment quality and patient safety!
Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer Patients
- December 13, 2019
Catherine Meyer, Magnus Dahlbom, Thomas Lindner, Sebastien Vauclin, et al.
Nucl Med 2020; 61:1171–1177 DOI: 10.2967/jnumed.119.236786
[AuntMinnie.com] DOSIsoft gets FDA nod for MU2net software
- November 11, 2019
Radiation oncology and nuclear medicine software developer DOSIsoft has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its MU2net software for independent secondary dose calculation for patient quality assurance.